2009
DOI: 10.1007/s00280-009-0991-z
|View full text |Cite
|
Sign up to set email alerts
|

Hydroxyurea and hydroxamic acid derivatives as antitumor drugs

Abstract: Hydroxyurea has been used for decades and it is still valuable for the treatment of some types of cancer. It inhibits ribonucleotide reductase (RNR) enzyme known to be crucial in the conversion of ribonucleotides into deoxyribonucleotides. However, nowadays the main focus has shifted to structurally similar hydroxamic acid derivatives that target specific enzymes involved in cancer progression such as histone deacetylases, matrix metalloproteinases and also RNR.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
86
0
1

Year Published

2010
2010
2021
2021

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 108 publications
(90 citation statements)
references
References 82 publications
1
86
0
1
Order By: Relevance
“…In contrast to camptothecin, hydroxyurea (HU) inactivates ribonucleotide reductase, ultimately leading to accumulation of double-stranded breaks near DNA replication forks (for review, see Saban and Bujak 2009). To evaluate the specificity of damage sensitivity and resistance, analysis was performed with HU as the drug challenge (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…In contrast to camptothecin, hydroxyurea (HU) inactivates ribonucleotide reductase, ultimately leading to accumulation of double-stranded breaks near DNA replication forks (for review, see Saban and Bujak 2009). To evaluate the specificity of damage sensitivity and resistance, analysis was performed with HU as the drug challenge (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Replication fork inhibition can also be obtained by the depletion of dNTPs, which can be achieved through the supply of HU (Wang and Liu, 2006;Saban and Bujak, 2009). Intriguingly, rtel1 mutants were tolerant to HU, as observed by a decreased reduction in root growth, compared with control plants ( Figure 6C).…”
Section: Rtel1 Suppresses Hrmentioning
confidence: 99%
“…Hydroxyurea is a widely used antimetabolite anticancer drug. It reduces the synthesis of deoxyribonucleotides through the inhibition of ribonuclease reductase 15 . Hydroxyurea can be used safely to treat patients with ET.…”
Section: Discussionmentioning
confidence: 99%